Chao-Chi Wang, PhD student (she/her/hers)

PhD student
Laboratory of Experimental Oncology, KU Leuven, Leuven Cancer Institute, Belgium

A second year PhD student with a background of master of biomedical engineering, currently doing research at KU Leuven, Belgium, the Department of Oncology - Laboratory of Experimental Oncology. The current research is mainly focusing on the in vivo novel drug testing in soft tissue sarcoma with patient derived xenograft models.

Poster(s):

• (P 43) UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-ASSOCIATED PROTEIN AS A POTENTIAL NEXT GENERATION MOLECULAR TARGET FOR TREATMENT OF GASTROINTESTINAL STROMAL TUMOR

• (P 254) A COLLECTION OF PATIENT-DERIVED XENOGRAFT MODELS OF GASTROINTESTINAL STROMAL TUMORS

• (P 349) THE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-ASSOCIATED PROTEIN (UPARAP) IS AN ATTRACTIVE TARGET FOR THE DEVELOPMENT OF ANTIBODY DRUG CONJUGATES FOR TREATMENT OF MESENCHYMAL MALIGNANCIES